Henry J. Fuchs

Insider Reports History

Identity
Location
Novato, CA
SEC record
Reporting signature
/s/ Tae Sang Yoo, Attorney-in-Fact
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Henry J. Fuchs:

Form 4 holding President, Worldwide R&D

BIOMARIN PHARMACEUTICAL INC

Security class
Common Stock
Shares / value
185,074
Estimated value
$15,712,783
Report date
13 Sep 2024
Price
$84.90
Ownership
Direct
Form 4 holding Director

Mirati Therapeutics, Inc.

Security class
Common Stock
Shares / value
10,465
Estimated value
$617,644
Report date
20 Jan 2023
Price
$59.02
Ownership
Direct
Form 4 holding President, Worldwide R&D

BIOMARIN PHARMACEUTICAL INC

Security class
Stock Option (Right to Buy Common Stock)
Shares / value
40,860
Estimated value
Report date
15 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Mirati Therapeutics, Inc.

Security class
Non Qualified Stock Option (right to buy)
Shares / value
7,520
Estimated value
Report date
20 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Henry J. Fuchs

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .